Skip to main content
Clinical Trials/NL-OMON42747
NL-OMON42747
Completed
N/A

PRostate Evaluation for Clinically Important disease: Sampling using Image-guidance Or Not? - PRECISIO

Radboud Universitair Medisch Centrum0 sites17 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostaatkanker detectie
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
17
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
September 21, 2017
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Men at least 18 years of age regerred with clinical suspicion of prostate cancer who have been advised to have a prostate biopsy.
  • PSA \* 20ng/ml within the previous 3 months
  • Suspected stage \* T2 on rectal examination (organ\-confined prostate cancer) within the previous 3 months

Exclusion Criteria

  • Prior prostate biopsy
  • Prior treatment for prostate cancer
  • Contrainidaction to MRI
  • Contraindication to prostate biopsy
  • evidence of untreated urinary tract infection
  • Previous hipreplacement surgery, metallic hip replacement

Outcomes

Primary Outcomes

Not specified

Similar Trials